Fmr LLC Ultragenyx Pharmaceutical Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Fmr LLC holds 2,604,588 shares of RARE stock, worth $88.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,604,588

Previous 381,422 582.86%

Holding current value

$88.5 Million

Previous $13.8 Million 585.7%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$31.06 - $39.3 $69.1 Million - $87.4 Million	2,223,166 Added 582.86%	2,604,588 $94.7 Million
Q1 2025 May 12, 2025	SELL	$36.21 - $45.78 $527,290 - $666,648	-14,562 Reduced 3.68%	381,422 $13.8 Million
Q4 2024 Feb 13, 2025	SELL	$42.07 - $57.72 $10.2 Million - $14 Million	-241,837 Reduced 37.92%	395,984 $16.7 Million
Q3 2024 Nov 13, 2024	SELL	$40.21 - $59.36 $393,937 - $581,549	-9,797 Reduced 1.51%	637,821 $35.4 Million
Q2 2024 Aug 13, 2024	SELL	$37.42 - $51.61 $5.03 Million - $6.94 Million	-134,414 Reduced 17.19%	647,618 $26.6 Million
Q1 2024 May 13, 2024	SELL	$43.02 - $53.69 $9.07 Million - $11.3 Million	-210,919 Reduced 21.24%	782,032 $36.5 Million
Q4 2023 Feb 13, 2024	SELL	$31.73 - $49.19 $1.11 Million - $1.71 Million	-34,834 Reduced 3.39%	992,951 $47.5 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $6.81 Million - $9.1 Million	195,108 Added 23.43%	1,027,785 $36.6 Million
Q2 2023 Aug 11, 2023	SELL	$37.35 - $52.15 $6.4 Million - $8.94 Million	-171,347 Reduced 17.07%	832,677 $38.4 Million
Q1 2023 May 11, 2023	SELL	$36.99 - $48.71 $2.78 Million - $3.66 Million	-75,050 Reduced 6.96%	1,004,024 $40.3 Million
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $3.35 Million - $4.6 Million	99,295 Added 10.13%	1,079,074 $50 Million
Q3 2022 Nov 10, 2022	SELL	$39.96 - $66.14 $7.13 Million - $11.8 Million	-178,463 Reduced 15.41%	979,779 $40.6 Million
Q2 2022 Aug 12, 2022	SELL	$45.8 - $85.4 $4.46 Million - $8.31 Million	-97,282 Reduced 7.75%	1,158,242 $69.1 Million
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $2.23 Million - $3.03 Million	-35,855 Reduced 2.78%	1,255,524 $91.2 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $9.61 Million - $11.5 Million	130,394 Added 11.23%	1,291,379 $109 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $22.3 Million - $29.3 Million	286,371 Added 32.74%	1,160,985 $105 Million
Q2 2021 Aug 13, 2021	BUY	$92.19 - $115.71 $80.6 Million - $101 Million	874,614 New	874,614 $83.4 Million

Others Institutions Holding RARE

# of Institutions

363

Shares Held

88.1M

Call Options Held

3.64M

Put Options Held

2.24M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.38B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account